Preclinical studies toward treating Fanconi anemia have been performed using adenine base editors and sgRNA in patient-derived and healthy donor-derived lymphoblastoid cell lines and CD34+ hematopoietic stem cells from healthy donors and patients with Fanconi anemia [193]. This evidence concerns the gene CD34 and Fanconi anemia.